Skip to main content
GENFLOW BIOSCIENCES PLC logo

GENFLOW BIOSCIENCES PLC — Investor Relations & Filings

Ticker · GENF ISIN · GB00BP2C3V08 LEI · 213800HVOFXRXVEGDN62 IL Professional, scientific and technical activities
Open in API
Filings indexed 142 across all filing types
Latest filing 2022-11-28 Regulatory Filings
Country GB United Kingdom
Listing IL GENF

About GENFLOW BIOSCIENCES PLC

https://genflowbio.com/

Genflow Biosciences PLC is a biotechnology company developing gene therapies that target the aging process. The company's primary mission is to slow or halt aging and reduce the incidence of age-related diseases in both humans and dogs, thereby extending healthspan. Its lead therapeutic candidate, GF-1002, is a gene therapy that delivers a centenarian variant of the Sirtuin 6 (SIRT6) gene. This specific gene variant has been identified in individuals who live to 100 years or more and has demonstrated promising results in pre-clinical studies.

Recent filings

Filing Released Lang Actions
Second Price Monitoring Extn
Regulatory Filings Classification · 99% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' multiple times. The content describes a 'Second Price Monitoring Extension' for a security, which is a specific, time-sensitive operational announcement related to trading mechanisms on the exchange. This type of general regulatory announcement that doesn't fit into specific financial reporting categories (like 10-K, ER, or DIV) is best classified under the general regulatory filing category, RNS (Regulatory Filings). The document length is short (1941 chars), but the content is the announcement itself, not an announcement *about* another report, making RNS more appropriate than RPA.
2022-11-28 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1924 characters) and contains the header 'RNS Number : 8311H' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Price Monitoring Extension' for a security's auction call period. This is a brief, specific regulatory announcement disseminated via the RNS system, which does not fit into the definitions for formal reports (10-K, IR, ER) or specific corporate actions (DIV, CAP, DIRS). Therefore, it falls best under the general regulatory announcement category.
2022-11-28 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1941 characters) and contains the header 'RNS Number : 7681H'. It discusses a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates it is a general regulatory announcement distributed via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, or MANG), the most appropriate classification is the general regulatory fallback category.
2022-11-28 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Price Monitoring Extension' for a security, which is a specific, short-form regulatory announcement related to trading mechanics, not a comprehensive financial report or a management change. Given the nature of the announcement (a brief update on trading status) and the explicit reference to RNS, the most appropriate classification is the general regulatory announcement category, RNS, as it is a standard regulatory notification that doesn't fit the more specific categories like ER, 10-K, or DIV. The document length is short (1924 chars), supporting the idea that it is a notification rather than a full report.
2022-11-28 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1941 characters) and contains the header 'RNS Number : 2635H'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory announcement that doesn't fit the specific categories (like DIRS, DIV, or DLST), the fallback category 'Regulatory Filings' (RNS) is the most appropriate classification.
2022-11-22 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1924 characters) and its primary content is an announcement regarding a 'Price Monitoring Extension' for a security, referencing the 'RNS Number' and stating that 'RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider'. This structure—a brief notification about a market event or administrative update, distributed via the RNS system—fits the definition of a general regulatory announcement that doesn't fit a more specific financial report category. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-11-22 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.